Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans
Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans have?
Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans has 344 citations in the OpenAlex counts ScholarIQ stores.
When was Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans published?
Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans has 1997 year in the ScholarIQ index.
What is the open-access status of Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans?
Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans has bronze oa status in the ScholarIQ index.
What is the DOI of Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans?
The DOI for Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans is on the source record.
What is the PMID of Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans?
The PMID for Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans is on the source record.
What is the OpenAlex record for Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans?
The OpenAlex for Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans is on the source record.